Gallo Gallo
Catanzaro, 88100, Italy
NCT Number: NCT04392245
Cross-sectional non-incentivized worldwide web survey.
A worldwide survey of 1050 respondents showed that proctologic practice has been seriously affected by the pandemic. Age, gender and level of hospital preparedness predicted the change of status of surgical and outpatient activities.
The results of our study may inform the development of strategies to reopen activities while protecting frontline healthcare workers.
Looking for future studies?
Notify MeAll sexes
Observational
Catanzaro, 88100, Italy
A 27-item survey (namely, 'ProctoLock 2020') was designed and developed by the authors using an online platform ('Online surveys' [formerly BOS - Bristol Online Survey], developed by the University of Bristol) in accordance with the American Association for Public Opinion Research (AAPOR) guidelines and the Checklist for Reporting Results of Internet E-Surveys [CHERRIES]
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Members of renowned scientific societies with an interest in coloproctology
Time frame: April 15th to 26th 2020
Societa Italiana di Chirurgia ColoRettale
Network
A Worldwide Survey on Proctologic Practice During Covid-19 Lockdown
Acronym: PROCTOLOCK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT04747249
COVID-19, Coronaviridae Infections
Caen, France
View Trial DetailsNCT06305793
COVID-19, Chronic Disease
Durham, North Carolina, United States
View Trial DetailsNCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial Details